TY - JOUR
T1 - Gadolinium-based hybrid nanoparticles as a positive MR contrast agent
AU - Hifumi, Hiroki
AU - Yamaoka, Seiichi
AU - Tanimoto, Akihiro
AU - Citterio, Daniel
AU - Suzuki, Koji
PY - 2006/11/29
Y1 - 2006/11/29
N2 - A new nanoparticulate inorganic-organic hybrid-type positive contrast agent (CA), PGP/dextran-K01, was synthesized based on a GdPO4 inorganic core as a relaxation-time-shortening moiety and a dextran-coating, which generates monodispersibility in water, a high relaxation-time-shortening effect by retaining a large number of water molecules in proximity of the core and toxicity reduction in in-vivo studies. This PGP/dextran-K01 nanoparticle has high r1 and r2 values and a significantly low r2/r1 value, 1.1, which is unprecedented and which is the lowest value among existing nanoparticulate CAs indicating that PGP/dextran-K01 is a positive contrast agent. Because of this low r2/r1 value and the nanoparticulate shape, PGP/dextran-K01 will be a useful clinical substitute for negative CAs based on iron oxides.
AB - A new nanoparticulate inorganic-organic hybrid-type positive contrast agent (CA), PGP/dextran-K01, was synthesized based on a GdPO4 inorganic core as a relaxation-time-shortening moiety and a dextran-coating, which generates monodispersibility in water, a high relaxation-time-shortening effect by retaining a large number of water molecules in proximity of the core and toxicity reduction in in-vivo studies. This PGP/dextran-K01 nanoparticle has high r1 and r2 values and a significantly low r2/r1 value, 1.1, which is unprecedented and which is the lowest value among existing nanoparticulate CAs indicating that PGP/dextran-K01 is a positive contrast agent. Because of this low r2/r1 value and the nanoparticulate shape, PGP/dextran-K01 will be a useful clinical substitute for negative CAs based on iron oxides.
UR - http://www.scopus.com/inward/record.url?scp=33845220050&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33845220050&partnerID=8YFLogxK
U2 - 10.1021/ja066442d
DO - 10.1021/ja066442d
M3 - Article
C2 - 17117851
AN - SCOPUS:33845220050
SN - 0002-7863
VL - 128
SP - 15090
EP - 15091
JO - Journal of the American Chemical Society
JF - Journal of the American Chemical Society
IS - 47
ER -